TMC Life Sciences Berhad Statistics
Total Valuation
KLSE:TMCLIFE has a market cap or net worth of MYR 792.56 million. The enterprise value is 863.89 million.
| Market Cap | 792.56M |
| Enterprise Value | 863.89M |
Important Dates
The next estimated earnings date is Monday, November 17, 2025.
| Earnings Date | Nov 17, 2025 |
| Ex-Dividend Date | Dec 8, 2025 |
Share Statistics
KLSE:TMCLIFE has 1.74 billion shares outstanding.
| Current Share Class | 1.74B |
| Shares Outstanding | 1.74B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 12.51% |
| Owned by Institutions (%) | 1.30% |
| Float | 296.88M |
Valuation Ratios
The trailing PE ratio is 219.81.
| PE Ratio | 219.81 |
| Forward PE | n/a |
| PS Ratio | 2.29 |
| PB Ratio | 0.93 |
| P/TBV Ratio | 1.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 35.22 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.35, with an EV/FCF ratio of -47.46.
| EV / Earnings | 239.57 |
| EV / Sales | 2.50 |
| EV / EBITDA | 21.35 |
| EV / EBIT | 70.74 |
| EV / FCF | -47.46 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.84 |
| Quick Ratio | 1.66 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 4.52 |
| Debt / FCF | -10.05 |
| Interest Coverage | 1.31 |
Financial Efficiency
Return on equity (ROE) is 0.41% and return on invested capital (ROIC) is 0.72%.
| Return on Equity (ROE) | 0.41% |
| Return on Assets (ROA) | 0.66% |
| Return on Invested Capital (ROIC) | 0.72% |
| Return on Capital Employed (ROCE) | 1.20% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.30 |
| Inventory Turnover | 17.14 |
Taxes
In the past 12 months, KLSE:TMCLIFE has paid 3.47 million in taxes.
| Income Tax | 3.47M |
| Effective Tax Rate | 49.01% |
Stock Price Statistics
The stock price has decreased by -13.76% in the last 52 weeks. The beta is 0.39, so KLSE:TMCLIFE's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -13.76% |
| 50-Day Moving Average | 0.42 |
| 200-Day Moving Average | 0.44 |
| Relative Strength Index (RSI) | 72.52 |
| Average Volume (20 Days) | 172,270 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:TMCLIFE had revenue of MYR 345.63 million and earned 3.61 million in profits. Earnings per share was 0.00.
| Revenue | 345.63M |
| Gross Profit | 109.67M |
| Operating Income | 12.21M |
| Pretax Income | 7.07M |
| Net Income | 3.61M |
| EBITDA | 37.81M |
| EBIT | 12.21M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 111.64 million in cash and 182.97 million in debt, giving a net cash position of -71.33 million or -0.04 per share.
| Cash & Cash Equivalents | 111.64M |
| Total Debt | 182.97M |
| Net Cash | -71.33M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | 853.04M |
| Book Value Per Share | 0.49 |
| Working Capital | 92.17M |
Cash Flow
In the last 12 months, operating cash flow was 22.51 million and capital expenditures -40.71 million, giving a free cash flow of -18.20 million.
| Operating Cash Flow | 22.51M |
| Capital Expenditures | -40.71M |
| Free Cash Flow | -18.20M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 31.73%, with operating and profit margins of 3.53% and 1.04%.
| Gross Margin | 31.73% |
| Operating Margin | 3.53% |
| Pretax Margin | 2.05% |
| Profit Margin | 1.04% |
| EBITDA Margin | 10.94% |
| EBIT Margin | 3.53% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.00, which amounts to a dividend yield of 0.40%.
| Dividend Per Share | 0.00 |
| Dividend Yield | 0.40% |
| Dividend Growth (YoY) | -91.61% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 1,070.88% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.40% |
| Earnings Yield | 0.45% |
| FCF Yield | -2.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KLSE:TMCLIFE has an Altman Z-Score of 2.63 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.63 |
| Piotroski F-Score | 6 |